Mayne Pharma Group's total assets for Q2 2025 were AU$1.13B, a decrease of -1.09% from the previous quarter. AU:MYX total liabilities were AU$684.53M for the fiscal quarter, a -0.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.